Bolero-6:Phase 2 Study of Everolimus plus Exemestane versus Everolimus or Capecitabine Monotherapy in HR+HER2- Advanced Breast Cancer

Ejlerstsen, Bent; JERUSALEM, Guy; Hurvitz, Sara; de Boer, Richard; Taran, Tetiana; Sahmoud, Tarek; Burris, Howard

Paper published in a journal (Scientific congresses and symposiums)

Ejlerstsen, Bent; JERUSALEM, Guy; Hurvitz, Sara et al.

2013 • In Journal of Clinical Oncology, 31, p. 660

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/156057

Files (2)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ASCO - Bolero 6 poster.pdf

Publisher postprint (1.37 MB)

Request a copy

Annexes

BOLERO-6 - Phase II study of everolimus plus exemestane versus everolimus ... - abstract.pdf

Publisher postprint (696.93 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Oncology

Author, co-author :

Ejlerstsen, Bent; Copenhagen University Hospital

JERUSALEM, Guy ; Centre Hospitalier Universitaire de Liège - CHU > Oncologie médicale

Hurvitz, Sara; UCLA Medical Center, Los Angeles

de Boer, Richard; Royal Melbourne Hospital, Melbourne

Taran, Tetiana; Novartis Pharmaceuticals Corporation, New Jersey

Sahmoud, Tarek; Novartis Pharmaceuticals Corporation, New Jersey

Burris, Howard; Sarah Cannon Research Institute, Nashville

Language :

English

Title :

Bolero-6:Phase 2 Study of Everolimus plus Exemestane versus Everolimus or Capecitabine Monotherapy in HR+HER2- Advanced Breast Cancer

Publication date :

2013

Event name :

American Society of Clinical Oncology

Event organizer :

American Society of Clinical Oncology

Event place :

Chicago, United States

Event date :

du 31 mai 2013 au 04 juin 2013

Audience :

International

Journal title :

Journal of Clinical Oncology

ISSN :

0732-183X

eISSN :

1527-7755

Publisher :

American Society of Clinical Oncology, Alexandria, United States - Virginia

Volume :

Pages :

abstract TPS660

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 17 September 2013

Statistics

Number of views

140 (9 by ULiège)

Number of downloads

4 (3 by ULiège)

More statistics